Patients currently taking metformin who are considering compounded semaglutide options, injectable or oral semaglutide forms, should maintain open communication with their healthcare providers about their treatment goals and any concerns
GLP-1 receptor agonists were originally a type of medication that people with type 2 diabetes were/are able to use to lower blood sugar levels
Fortunately, Spectrum reported no adverse events related to this recall, but the precaution reflects the seriousness of even small quality issues in essential medicines
Can I switch to a different GLP-1 medication after semaglutide leaves my system
Expansion of coverage under Medicare of GLP-1s to treat obesity under the BALANCE model is likely to increase utilization above current levels, as Medicare begins to meet the demand for obesity drugs among beneficiaries who have been unable to access or afford these medications to date
Another issue is infant metabolism